<DOC>
	<DOCNO>NCT00697385</DOCNO>
	<brief_summary>The high percentage failure use available non-surgical option treat menorrhagia woman bleed disorder show continue need innovative treatment . This lead development protocol order make available tranexamic acid potentially effective menorrhagia therapy option woman underlie bleed disorder . We anticipate Tranexamic Acid may beneficial choice control menorrhagia bleed disorder patient .</brief_summary>
	<brief_title>The Use Cyclokapron Treatment Management Women With Bleeding Disorders</brief_title>
	<detailed_description>Women heavy period diagnose bleed disorder prescribe cyclokapron pill take period . Their period assess 3 6 month fill pictorial blood assessment chart . If drug appear work adverse effect patient continue take medication long available follow investigator every 6 month .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>menstruate woman regardless age Women heavy period measure pictorial blood assessment chart Women diagnose bleed disorder Acquired defective color vision Factor VIII , Factor IX , FactorXI level &gt; 250 % An inherited thrombophilic defect detect positive family personal history thrombosis Current use oral contraceptive</criteria>
	<gender>Female</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>